EGFR Mutation Testing for Squamous Cell Lung Carcinoma

[1] Liam CK, 2012, RESPIROLOGY, V17, P92

[2] Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma in Malaysian Patients [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (06) : 766 - 772

[3] Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (07) : 823 - 859

[4] Response to Erlotinib in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancers with a Squamous or Squamous-like Component [J]. MOLECULAR CANCER THERAPEUTICS, 2012, 11 (11) : 2535 - 2540

[5] Clinical and Testing Protocols for the Analysis of Epidermal Growth Factor Receptor Mutations in East Asian Patients with Non-small Cell Lung Cancer A Combined Clinical-Molecular Pathological Approach [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (10) : 1663 - 1669

[1] Liam CK, 2012, RESPIROLOGY, V17, P92

[2] Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma in Malaysian Patients [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (06) : 766 - 772

[3] Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (07) : 823 - 859

[4] Response to Erlotinib in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancers with a Squamous or Squamous-like Component [J]. MOLECULAR CANCER THERAPEUTICS, 2012, 11 (11) : 2535 - 2540

[5] Clinical and Testing Protocols for the Analysis of Epidermal Growth Factor Receptor Mutations in East Asian Patients with Non-small Cell Lung Cancer A Combined Clinical-Molecular Pathological Approach [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (10) : 1663 - 1669